Targeting acute lung injury (ALI), Zheng et al. designed and synthesized 40 diimide-indole derivatives and evaluated their potential for treating ALI by targeting the NF-κB signaling pathway [156]. Here, NFKB1 is linked to acute respiratory distress syndrome.